Acyl sulfamides for treatment of obesity, diabetes and lipid disorders

Details for Australian Patent Application No. 2002240235 (hide)

Owner Merck & Co., Inc.

Inventors Acton, John, J., III; Jones, A. Brian

Agent Spruson & Ferguson

Pub. Number AU-B-2002240235

PCT Pub. Number WO2002/060388

Priority 60/264,955 30.01.01 US

Filing date 25 January 2002

Wipo publication date 12 August 2002

Acceptance publication date 6 July 2006

International Classifications

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

C07C 67/02 (2006.01) Preparation of carboxylic acid esters

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-B-2002240235

6 July 2006 Application Accepted

  Published as AU-B-2002240235

2 November 2006 Standard Patent Sealed

19 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002240236-ENDOSCOPE SYSTEM AND METHOD OF USE

2002240234-HALO ORTHOSIS